Dean Slagel - Net Worth and Insider Trading
Dean Slagel Net Worth
The estimated net worth of Dean Slagel is at least $328,561 dollars as of 2024-09-20. Dean Slagel is the Director of Cara Therapeutics Inc and owns about 1,064,338 shares of Cara Therapeutics Inc (CARA) stock worth over $328,561. Details can be seen in Dean Slagel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dean Slagel has not made any transactions after 2017-06-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dean Slagel
Dean Slagel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dean Slagel owns 1 companies in total, including Cara Therapeutics Inc (CARA) .
Click here to see the complete history of Dean Slagel’s form 4 insider trades.
Insider Ownership Summary of Dean Slagel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2017-06-29 | director |
Dean Slagel Latest Holdings Summary
Dean Slagel currently owns a total of 1 stock. Dean Slagel owns 1,064,338 shares of Cara Therapeutics Inc (CARA) as of June 29, 2017, with a value of $328,561.
Latest Holdings of Dean Slagel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2017-06-29 | 1,064,338 | 0.31 | 328,561 |
Holding Weightings of Dean Slagel
Dean Slagel Form 4 Trading Tracker
According to the SEC Form 4 filings, Dean Slagel has made a total of 0 transactions in Cara Therapeutics Inc (CARA) over the past 5 years. The most-recent trade in Cara Therapeutics Inc is the sale of 250,000 shares on June 29, 2017, which brought Dean Slagel around $6 Million.
Insider Trading History of Dean Slagel
- 1
Dean Slagel Trading Performance
Dean Slagel Ownership Network
Dean Slagel Owned Company Details
What does Cara Therapeutics Inc do?
Who are the key executives at Cara Therapeutics Inc?
Dean Slagel is the director of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .
Cara Therapeutics Inc (CARA) Insider Trades Summary
Over the past 18 months, Dean Slagel made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 60,613 shares made by Christopher Posner , a net sale of 7,957 shares made by Joana Goncalves , and a net sale of 7,717 shares made by Scott Terrillion .
In summary, during the past 3 months, insiders sold 4,149 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 4,149 shares. During the past 18 months, 82,013 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 82,013 shares.
Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cara Therapeutics Inc Insider Transactions
Dean Slagel Mailing Address
Above is the net worth, insider trading, and ownership report for Dean Slagel. You might contact Dean Slagel via mailing address: C/o Esperante Ventures, Po Box 30127, Limhamn V7 Se-20061.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
